Stop the Revolving Door: An ED-based Intervention to Improve the Treatment of Uncontrolled Diabetes
Context:
Patients with undiagnosed Type 2 Diabetes (T2D) often first present to the Emergency Department (ED), but if they are not in ketoacidosis (DKA) or in a hyperosmolar state (HHS), they are usually discharged with variable treatment or follow-up. Many patients with poorly controlled known T2D also are frequent utilizers of the ED, but they seldom benefit from acute treatment and release practices. We developed electronic health record (EHR) alerts and an observation stay protocol to improve the ED treatment of patients with poorly controlled known or new T2D.
Research Question:
Do EHR alerts improve the screening of poorly controlled known or new T2D (HbA1c ) in the ED and does a dedicated protocol in the observation unit result in better glycemic control and follow-up care?
Methods:
We are conducting a pragmatic, interrupted time series trial at a large, urban academic medical center using an EHR-based, alert-driven protocol for patients presenting to the ED with hyperglycemia (glucose ≥ 250 mg/dL). The first alert suggests ordering an HbA1c test—if the HbA1c is ≥ 10%, a second alert recommends admission to the observation unit for intensive glucose control, diabetes education, endocrinology consultation, and medication titration. We will be assessing adherence with the recommended ED treatment protocol, receipt of a T2D-related follow-up appointment within 4 weeks, and HbA1c 1% reduction in 3 months.
1. Magee, M.F., et al., Synergy to reduce emergency department visits for uncontrolled hyperglycemia. Diabetes Educ, 2013. 39(3): p. 354-64.
2. Charfen, M.A., et al., Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Acad Emerg Med, 2009. 16(5): p. 394-402.
3. Magee, M.F. and C. Nassar, Hemoglobin A1c testing in an emergency department. J Diabetes Sci Technol, 2011. 5(6): p. 1437-43.
4. Arora, S., et al., A randomized, controlled trial of oral versus intravenous fluids for lowering blood glucose in emergency department patients with hyperglycemia. CJEM, 2014. 16(3): p. 214-9.
5. Driver, B.E., et al., Discharge Glucose Is Not Associated With Short-Term Adverse Outcomes in Emergency Department Patients With Moderate to Severe Hyperglycemia. Ann Emerg Med, 2016. 68(6): p. 697-705 e3.
6. Driver, B.E., et al., Comparison of two glycemic discharge goals in ED patients with hyperglycemia, a randomized trial. Am J Emerg Med, 2019. 37(7): p. 1295-1300.
7. Driver, B.E., et al., The Association of Emergency Department Treatments for Hyperglycemia with Glucose Reduction and Emergency Department Length of Stay. J Emerg Med, 2017. 53(6): p. 791-797.
8. Koscal, L.J., et al., Intravenous insulin for the management of non-emergent hyperglycemia in the emergency department. Am J Emerg Med, 2021. 45: p. 335-339.
9. Ginde, A.A., et al., Multicenter survey of emergency physician management and referral for hyperglycemia. J Emerg Med, 2010. 38(2): p. 264-70.
10. American Diabetes Association Professional Practice, C., 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care, 2024. 47(Suppl 1): p. S158-S178.
11. Babu, A., et al., Safe and simple emergency department discharge therapy for patients with type 2 diabetes mellitus and severe hyperglycemia. Endocr Pract, 2009. 15(7): p. 696-704.
12. Bowen, M.E., et al., Random blood glucose: a robust risk factor for type 2 diabetes. J Clin Endocrinol Metab, 2015. 100(4): p. 1503-10.
13. Echouffo-Tcheugui, J.B. and R. Garg, Management of Hyperglycemia and Diabetes in the Emergency Department. Curr Diab Rep, 2017. 17(8): p. 56.
14. Gale, J., et al., Unscheduled emergency department presentations with diabetes: Identifying high risk characteristics. Australas Emerg Care, 2023. 26(3): p. 205-210.
15. Holman, R.R., et al., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008. 359(15): p. 1577-89.
16. King, W.M.t., M.T. McDermott, and J.M. Trujillo, Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study. Diabetes Ther, 2013. 4(2): p. 375-84.
17. Koziatek, C.A., et al., Neighborhood-Level Risk Factors for Severe Hyperglycemia among Emergency Department Patients without a Prior Diabetes Diagnosis. J Urban Health, 2023. 100(4): p. 802-810.
18. Lachin, J.M., D.M. Nathan, and D.E.R. Group, Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care, 2021. 44(10): p. 2216-24.
19. Schwartz, X., et al., Emergency Department Management of Uncomplicated Hyperglycemia in Patients without History of Diabetes. J Emerg Med, 2023. 65(2): p. e81-e92.
20. UKPDS, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998. 352(9131): p. 854-65.